Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading provider of hormone optimization, has announced the launch of a new Men’s Health Division with the mission of redefining wellness for men through innovation in hormone education and optimization. Coinciding with National Men’s Health Month and headed by Biote General Manager John Denne, this new division will focus on increasing awareness, education and access to treatment for the estimated 39% of men over the age of 45 who are affected by testosterone deficiency in the United States.

“Men tend to think about health as the absence of disease and are reluctant to ask their healthcare provider about symptoms of low testosterone such as poor sleep, low sex drive, anxiety and depression, and low energy,” explains Terry Weber, CEO of Biote. “Establishing a division dedicated specifically to men was a logical step in our commitment to increase the number of providers in our network who are educated and trained to meet the specific needs and preferences of male patients.”

Low testosterone, also called hypogonadism, can be detected with a blood test and is diagnosed when a person has low testosterone levels while also experiencing symptoms. In general, men experience a 44% reduction of testosterone between ages 30 and 74 at the rate of roughly 1 percent each year, unlike women who experience a sudden drop in hormone levels at menopause. However, despite access to care, only 12% of clinically symptomatic men are successfully treated for low testosterone.

“When you ask a man about his cholesterol or blood pressure level he will usually know if he is in a healthy range, but if you ask about his hormone levels, he will likely have no idea,” says Marc Beer, Executive Chairman of Biote. “This new division will focus on educating and motivating men to recognize and seek treatment for symptoms of low testosterone. At the same time, we are providing the necessary tools and resources for urologists and internal medicine practitioners to effectively treat these male patients who come through the door looking for solutions.”

Roger Dmochowski, MD, MMHC, FACS and a member of the Biote medical science advisory board, states “Ascertaining the hormonal health of a male patient should be an essential component of any primary care or urological examination. In addition to more obvious symptoms, low testosterone has been associated with a wide range of insidious health issues including cardiovascular risk and osteoporosis.”